Diabetic Foot Ulcer Treatment Market Size, Share, Growth Analysis, By Product(Wound Care Dressing, Wound Care Device, Biologics and Others), By Type(Neuropathic Ulcer, Ischemic Ulcer, and Neuroischemic Ulcers), By End User(Hospitals, Homecare Settings, and Others), By Region - Industry Forecast 2024-2031

Global Diabetic Foot Ulcer Treatment Market size was valued at USD 4.4 billion in 2022, USD 4.64 billion in 2023 and is projected to grow USD 6.70 billion by 2031, growing at a CAGR of 5.4% in the forecast period (2024-2031).

The market for diabetic foot ulcer treatments is expanding due to several causes, including an increase in the number of people with diabetes, an increase in the senior population, and developments in wound care management technology. One major factor propelling the market is the increasing incidence of diabetes worldwide. For example, according to the Centers for Disease Control and Prevention's (CDC) 2022 National Diabetes Statistics Report, 130 million persons in the United States have diabetes or prediabetes. The need for efficient diabetic foot ulcer treatment alternatives is growing in tandem with the rising prevalence of diabetes.

Another factor propelling the diabetic foot ulcer treatment market is the ageing population. As people age, they become more susceptible to chronic illnesses including diabetes, peripheral neuropathy, and peripheral artery disease, all of which raise the risk of foot ulcers. The need for innovative diabetic foot ulcer treatments is driven by the increasing number of elderly individuals. Furthermore, the treatment of diabetic foot ulcers has been completely transformed by developments in wound care technologies. Improvements in wound healing and faster wound closure have been made possible by advancements in dressings, bioactive materials, negative pressure wound therapy (NPWT), and hyperbaric oxygen therapy (HBOT). The market is expanding due to the patients and healthcare providers drawn in by these technological developments.